药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxamniquine
Tasimelteon
The metabolism of Tasimelteon can be decreased when combined with Nilotinib.
Oxamniquine
Suvorexant
The metabolism of Suvorexant can be decreased when combined with Nilotinib.
Oxamniquine
Vorapaxar
The metabolism of Vorapaxar can be decreased when combined with Nilotinib.
Oxamniquine
Lacosamide
The metabolism of Lacosamide can be decreased when combined with Nilotinib.
Oxamniquine
Allylestrenol
The metabolism of Allylestrenol can be decreased when combined with Nilotinib.
Oxamniquine
Drospirenone
The metabolism of Drospirenone can be decreased when combined with Nilotinib.
Oxamniquine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Nilotinib.
Oxamniquine
Penfluridol
The risk or severity of QTc prolongation can be increased when Penfluridol is combined with Nilotinib.
Oxamniquine
Lorcainide
The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Nilotinib.
Oxamniquine
Bunaftine
The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Nilotinib.
Oxamniquine
Nizofenone
The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Nilotinib.
Oxamniquine
Otilonium
The risk or severity of QTc prolongation can be increased when Otilonium is combined with Nilotinib.
Oxamniquine
Sultopride
The risk or severity of QTc prolongation can be increased when Sultopride is combined with Nilotinib.
Oxamniquine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Nilotinib.
Oxamniquine
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Nilotinib.
Oxamniquine
Abexinostat
The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Nilotinib.
Oxamniquine
Mizolastine
The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Nilotinib.
Oxamniquine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Nilotinib.
Oxamniquine
Simendan
The risk or severity of QTc prolongation can be increased when Simendan is combined with Nilotinib.
Oxamniquine
CUDC-101
The risk or severity of QTc prolongation can be increased when CUDC-101 is combined with Nilotinib.